Ambea signed an agreement to acquire the care operations of Aleris

Stockholm (Sweden), 16 October 2018 - Ambea AB (publ) ("Ambea"), a former Triton III portfolio company today listed on Nasdaq Stockholm, have signed an agreement to acquire the care operations of Aleris in Norway, Sweden and Denmark ("Aleris Care") . Following the acquisition, Ambea will be the largest care provider in the Nordic region with operations in Sweden, Norway and Denmark. The acquisition will create a stable platform for future organic growth and significant potential for synergies, purchasing coordination and exchange of experiences in the areas of business and quality development.

The annual sales for the new group for the period 1 July 2017 to 30 June 2018 amounted to approximately SEK 10,602 million, of which Ambea accounted for SEK 5,937 million and Aleris Care for SEK 4,665 million.

The transaction is subject to regulatory approval by the relevant competition authorities and closing is expected to occur during the first quarter of 2019, however no later than in the second quarter of 2019.

“The acquisition increases our capacity for organic growth under own management. We will gain a broader growth platform with leading positions in three countries and a strengthened pipeline with new beds. Furthermore, we will create major opportunities for synergies, purchasing coordination and exchange of experiences in the areas of operational and quality development. This will outlay the foundation for higher quality and thus also higher profitability in our operations.”, says Fredrik Gren, President and CEO of Ambea.

In connection with the transaction, Ambea intends to carry out a share issue, with preferential rights to existing shareholders, in the amount of approximately SEK 1.2 billion. The larger shareholders ACTR Holding AB and ACTOR SCA, controlled by KKR and Triton and representing approximately 50.1 per cent of the total number of shares and votes in Ambea, intend to vote in favour of the Rights Issue at a general meeting and to subscribe for their respective pro-rata shares in the Rights Issue. The Rights Issue is expected to be resolved and completed during the first half of 2019.

Triton acquired Ambea Sweden in 2010 in partnership with KKR. Over the years, Triton and KKR have supported the company’s continued growth through investments for improved quality. The company has made significant progress to becoming a Swedish quality leader. Ambea was successfully listed on Nasdaq Stockholm on 31 March 2017.